Caplin Point Laboratories Ltd
₹2016.60
(1.06%)
Sat, 30 May 2026, 07:48 pm
Health Technology
Pharmaceuticals: Major
24.5KCaplin Point Laboratories Share Price Live Chart
1 Day
(1.06%)
No Result Found
Summary
Market Cap
15431.13
Net Profit
541.09
P/B
5.78
Sector P/E
34.30
P/E
28.38
EV/EBITDA
19.69
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
22.86
ROCE
26.03
Debt/Equity
0
EPS (TTM)
84.36
Dividend Yield
0.20
Book Value
471.83
Interest Cover
1110.48
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (13x coverage).
- Dividends after 3 years are expected to be thoroughly covered by earnings (10.6x coverage).
- Dividends per share have been stable in the past 10 years.
- Cash flow for Caplin Point Laboratories is expected to increase by more than 50% in 2 years time.
- Caplin Point Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Caplin Point Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Caplin Point Laboratories's earnings are expected to grow by 18.2% yearly, however this is not considered high growth (20% yearly).
- Caplin Point Laboratories's earnings growth is positive but not above the India market average.
- Caplin Point Laboratories's net income is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 70.57 | 70.57 | 70.57 | 70.56 | 70.56 |
| FII | 6.15 | 6.56 | 6.48 | 6.14 | 5.70 |
| DII | 2.14 | 2.05 | 2.10 | 2.22 | 2.01 |
| Public | 21.14 | 20.82 | 20.85 | 21.08 | 21.73 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2255.87 | 1964.07 | 1836.53 | 1672.27 | 1544.73 | 1380.47 | 1088.67 |
| Fibonacci | 1964.07 | 1852.60 | 1783.73 | 1672.27 | 1560.80 | 1491.93 | 1380.47 |
| Camarilla | 1789.24 | 1762.50 | 1735.75 | 1672.27 | 1682.25 | 1655.50 | 1628.76 |
Pivots Level: Classic
R3
+583.60
2255.87
R2
+291.80
1964.07
R1
+164.27
1836.53
S1
-127.53
1544.73
S2
-291.80
1380.47
S3
-583.60
1088.67
Moving Average
Period
Value
10-EMA
2005.75
20-EMA
1943.32
30-EMA
1894.69
50-EMA
1841.05
100-EMA
1821.60
200-EMA
1860.10
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 14 May 2026 | board-meetings | Accounts, Interim Dividend | |
| 14 May 2026 | dividend | ₹4.00 Dividend /Share | 30 May 2026 |
| 05 Feb 2026 | board-meetings | Quarterly Results | |
| 05 Nov 2025 | board-meetings | Quarterly Results | |
| 12 Aug 2025 | dividend | Final Dividend - Rs. - 3 | 12 Sept 2025 |
| 07 Aug 2025 | agm | ||
| 07 Aug 2025 | dividend | ₹3.00 Dividend /Share | 12 Sept 2025 |
| 15 May 2025 | dividend | ₹3.00 Dividend /Share | 30 May 2025 |
| 30 Apr 2025 | dividend | Interim Dividend - Rs. - 3 | 30 May 2025 |
| 23 Aug 2024 | dividend | Dividend - Rs 2.50 Per Share | 23 Sept 2024 |
Peer Comparison
Caplin Point Laboratories Ltd
Divis Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Cipla Ltd
Caplin Point Laboratories Ltd About
Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1990
Headquarters
CEO
C C Paarthipan
Employees
Contact
Website
http://www.caplinpoint.net
investor@caplinpoint.net; info@caplinpoint.net
Phone
91-44-24968000/71148000/28156653
Location
Ashvich Towers 3rd Floor, No 3 Developed Plots Ind Estat, Chennai, Tamil Nadu, 600096
Caplin Point Laboratories Ltd Company History
| Year | History |
|---|---|
| 2018 |
|
| 2019 |
|
| 2020 |
|
| 2021 |
|
| 2023 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 396355 | 1899.6 | 26 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 396355 | 1901.28 | 26 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 444478 | 1763.58 | 19 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 444478 | 1761.72 | 19 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 381306 | 908.19 | 09 Sept 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 381306 | 908.54 | 09 Sept 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 414981 | 957.62 | 27 Jul 2021 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 414981 | 957.37 | 27 Jul 2021 |
| XTX MARKETS LLP | bulk | Sell | 460816 | 910.58 | 26 Jul 2021 |
| XTX MARKETS LLP | bulk | Buy | 464203 | 908.91 | 26 Jul 2021 |